WuXi NextCODE completed a Series B fundraising with $240 million in new capital for its genomics CRO operations. In May, the company closed the first tranche of the round. NextCODE is WuXi AppTec’s platform for genomic data, and Dr. Ge Li, Chairman of the company, said NextCODE is working towards sequencing millions of genomes. Two years ago, WuXi AppTec paid $65 million to acquire NextCODE, which had developed a genomics platform based on the largely homogeneous genomic profile of Iceland. Sequoia China led the B round.
Source: China Biotoday
